Articles from MTF Biologics

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has appointed two new key leaders to its board of directors. Dr. Donald Hackbarth has been named Chair of the Board of Directors, succeeding Dr. William Tomford after his dedicated tenure, and Sharon Gabrielson, BSN, MBA, has been named Vice Chair of the Board. These changes mark a new chapter in the organization’s leadership.

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $1,000,000 in funding to eight researchers through its 2024 Innovation in Allograft Translational Research Grant Program.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts and advancing the science of tissue transplantation, today announced two of its aseptically processed allografts, AmnioBand® Membrane, an allograft placental matrix, and AlloPatch® Pliable, an allograft dermis matrix, are among the select few tissues to remain covered under the new Medicare medical coverage guidelines. These new guidelines are based on published clinical evidence and reduced the number of covered tissues from over 200 to 17, reaffirming MTF Biologics’ commitment to providing clinically proven solutions for wound care.

MTF Biologics, a global leader in tissue-based solutions, and Centurion Therapeutics, a pioneering distributor in the medical field, today announced they have entered into a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies. The agreement, which is an expansion of a five-year collaboration between MTF Biologics and Centurion, grants Centurion exclusive distribution rights for a range of MTF Biologics’ tissue technologies, including placental, dermal, and adipose tissues. The tissue forms covered in the agreement include Amnioband® Membrane, Salera® Membrane, Salera® Mini-Membrane, Allopatch® Pliable, Allopatch® Meshed, Somagen® Meshed Dermal Matrix, and Leneva® Adipose Matrix. The agreement also includes provisions for ongoing training, marketing, and support to ensure effective promotion and distribution of the tissue forms.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, has announced the appointment of Mia Talmor, MD, to the MTF Biologics Board of Directors.

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $930,000 in funding to six researchers worldwide through its 2023 Innovation in Allograft Translational Research Grant Program.

Donor Network West, an organization that saves and heals lives by facilitating organ and tissue recovery for transplantation and research, and MTF Biologics, a global non-profit organization that saves and heals lives by honoring donated gifts, hosted a memorial event honoring organ and tissue donor and U.S. Marine, Matthew Messina at MTF Biologics Tuesday, December 12, 2023.

MTF Biologics®, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) to begin a clinical study confirming the safety and effectiveness of FlexHD® Pliable for implant-based breast reconstruction. This marks the first IDE approval for a human acellular dermal matrix for breast reconstruction granted by FDA and is an important milestone in MTF Biologics pursuing Pre-Market Approval (PMA) for FlexHD® Pliable.

MTF Biologics will receive the 2023 Corporate Humanitarian Award at Mission Plasticos’ annual Celebration of Global Friendships: Emerald City event on September 9, 2023, in Newport Beach, Calif. Mission Plasticos has been transforming lives on a global and local scale in communities in need over the last 24 years – providing reconstructive surgery, training local medical professionals, and supporting ongoing research focused on improving standards of care.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, is introducing AlloPatch® Pliable Meshed to its line of premier, innovative and effective wound care solutions. AlloPatch® Pliable Meshed is an acellular human reticular dermal allograft designed to help heal difficult to treat wounds including diabetic foot ulcers and venous leg ulcers.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined its Board of Directors.

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program.

A recent study in Plastic and Reconstructive Surgery, the Journal of the American Society of Plastic Surgeons, reports that AmnioBand® Membrane, an aseptically processed, dehydrated human amnion/chorion allograft (dHACA) developed by MTF Biologics, offers greater wound closure for those with chronic venous leg ulcers than standard of care alone. In fact, AmnioBand was shown to achieve full wound closure in 75 percent of these difficult to treat wounds after just 12 weeks of treatment. These results indicate that AmnioBand is one of the most cost-effective advanced treatment options for venous leg ulcers available today.

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $1 million in funding to nine researchers across the nation through its 2021 Extramural Research Grants Program.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing science, today announced it has named George Herrera Executive Vice President, Donor Services. Herrera succeeds Martha Anderson, who is retiring on October 31, 2021, following a more than 30-year tenure with the organization.

MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation has announced the appointment of Sharon Gabrielson, Symeria Hudson and David McAllister, MD, to the MTF Biologics Board of Directors.

MTF Biologics is pleased to announce that it was again named a 2021 Top Workplace by NJ.com, having also received the recognition in 2020. Ranking #3 in the state in the large company category (more than 500 employees), MTF also earned the Manager Award. This is the third year that Energage, LLC, an employee engagement platform, has partnered with NJ.com and Jersey’s Best to recognize an elite group of companies from across the Garden State.